Across TCGA pan-cancer cohorts, KRTAP10-1 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of KRTAP10-1’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where KRTAP10-1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types KRTAP10-1 is over-expressed in tumor.
LUSC are the cancer types where KRTAP10-1 tumor–normal differential expression is most reproducible.